A collaborative platform for paperless relicensing
A collaborative platform for paperless relicensing
While advanced systemic mastocytosis (SM) is a rare disorder, treatment options are still available; find out more about management strategies here!
| Duration : 05:30:00 hours |
| Content provider : Akshaya Patra Foundation |
| Date launched at CMEPEDIA : July 4, 2024 |
| Expiry date of course : May 7, 2025 |
| Module size : 0.45MB |
| Price : ₹0.00 - ₹315.00(Some professional bodies apply charges, even if the content is free of cost. Log in to check whether your professional body does.) |
Cmepedia requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
| Category | Accreditor | Credits | Accreditation details |
|---|---|---|---|
| Cardiologist, Emergency physician | Accreditation Council for Continuing Medical Education | 1 ACCME | ACCME |
| General surgeon | Royal Australasian College of Surgeons | 5 RACS CPD Credit | Cmepedia, designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim credit commensurate with their participation in the activity. Upon successful completion of this CME activity, including participation in the evaluation component, participants can earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. The number of MOC points earned will be equivalent to the amount of CME credits claimed for the activity. The CME activity provider is responsible for submitting participant completion information to ACCME to grant ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity |
|
Cardiologist, Anesthesist, Emergency physician, Allergist, A...Read More |
Dutch Medical Society Model | 1 DMSM Credits | Dutch |
| Endorsed by | Accredited by | Conversion credits |
|---|---|---|
| Bangalore XYZ council | Dutch Medical Society Model | 1 BXC Credits |
For quite some time, our treatment armamentarium for patients with advSM consisted of incompletely effective therapies associated with significant toxicity. Now with the availability of targeted approaches, clinicians can provide patients with more efficacious and safer options. However, there is room for growth: the safety of current targeted approaches still needs to be improved, especially given severe adverse events such as intracranial hemorrhage. With this in mind, new trials are investigating novel agents (eg, BLU-263, bezuclastinib) that do not readily cross the blood-brain barrier, with the hope of reducing this potentially fatal event seen with current TKIs. Lastly, it is important to note that clinicians should consider referring patients with advSM to a specialized institution. Here, patients can receive individualized treatment and optimal care under the watch of a collaborative multidisciplinary team with expertise in managing symptoms and complications of advSM.
₹0.00 - ₹315.00
₹132.83 - ₹3282.83
₹0.00 - ₹315.00
₹0.00 - ₹315.00
₹0.00 - ₹420.00
₹0.00 - ₹315.00
₹495.08 - ₹6627.08
₹12.08 - ₹3162.08
₹0.00 - ₹315.00
